Ignite Creation Date:
2024-05-06 @ 3:06 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02201992
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2014-07-21
Brief Title:
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations An ALCHEMIST Treatment Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Eastern Cooperative Oncology Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-03-23
Start Date Type:
ACTUAL
Primary Completion Date:
2036-05-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2036-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2014-07-21
First Submit QC Date:
July 24 2014
Study First Post Date:
2014-07-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-29
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL